https://www.jacobiopharma.com/en/JAB2485-en-clinicaltrial
JAB-2485 monotherapy in adult participants with advanced solid tumors | Jacobio Pharma
The primary objective of this study is to evaluate the safety and tolerability of JAB-2485 monotherapy to determine the maximum tolerated dose (MTD) and...
advanced solid tumorsadult participants
https://app.quri.ai/trials/NCT06144671/gt201-injection-for-the-treatment-of-advanced-solid-tumors
GT201 Injection For The Treatment Of Advanced Solid Tumors (NCTNCT06144671) - Patient Guide &...
Connect with this clinical trial through Quri.ai's free matching service. GT201 Injection For The Treatment Of Advanced Solid Tumors (NCTNCT06144671). We'll...
advanced solid tumorsfor the
https://ctv.veeva.com/study/emd-521873-in-advanced-solid-tumors-mtd-finding
EMD 521873 in Advanced Solid Tumors, MTD Finding
Primary trial objective in this three arm trial is to assess the safety and tolerability of EMD 521873, and to determine whether the maximum tolerated dose...
advanced solid tumorsemdmtdfinding
https://www.bmsstudyconnect.com/no/no/clinical-trials/NCT03093116.html
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or...
Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and...
https://www.knowcancer.com/cancer-trials/NCT01011972/
A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors
XMT-1107 has been shown in nonclinical studies to slow the growth of tumors. These effects may result from blocking the growth of new blood vessels tha
a study